Asset and Portfolio Management2018-02-04T10:58:57+00:00

Asset and Portfolio Management

Deallus’ comprehensive and in-depth approach to competitive asset and portfolio lifecycle management delivers the assurance you need to make the right decisions for your NME, acquired asset, or even for an entire portfolio or business unit.

By offering reliable and resourceful analytics on a wide range of interrelated issues, including R&D activities, in-licensing and M&A, therapeutic area targeting, portfolio and indication prioritisation, lifecycle and LoE planning, and more, Deallus partners with our clients to achieve optimised value for your investments and astute ROI insights to support and maximise the performance of commercial portfolios.

Deallus Therapeutic area and commercial prospecting

Therapeutic area and commercial prospecting

Identifying the competitive landscape in order to accurately inform therapy area and commercial prospects

Deallus LoE and Peri LoE planning

LoE and Peri LoE planning

Managing and prioritising assets within a portfolio to balance resources and maximise position within a therapeutic area

Building and optimising portfolios

Interpreting opportunities for partnership, co-promotion, co-marketing, and other investments whilst holistically assessing the product lifecycle to maximise potential

Asset and portfolio evolution

Incorporating technology assessments, payer trends, and more to understand how to establish and maintain portfolio relevance

Find out more